A relatively high proportion of patients diagnosed with primary CNS lymphoma will experience recurrent disease, yet therapy options are limited in salvage therapy. | Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B O AD therapy for the treatment of primary central nervous system lymphoma PCNSL